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Methods: Synovial ﬂuid samples were obtained from 100 OA patients (BMI
30.8±0.6kg/m2, age 70.0±1.0 years; mean±SEM) under total knee arthro-
plasty, and leptin, IL-6 and MMPs were measured by immunoassays (ELISA
and multiplex bead array method, Luminex). Cartilage samples collected
from OA patients undergoing knee replacement surgery were placed in
tissue culture and exposed to leptin.
Results: In tissue culture experiments, leptin (alone and in the presence of
IL-1β) enhanced production of IL-6, MMP-1, MMP-3 and MMP-13 in human
OA cartilage. In addition, leptin enhanced expression/production of inﬂam-
matory factors, nitric oxide (NO), inducible nitric oxide synthase (iNOS),
prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2) and IL-8. The effect of
leptin on these mediators was mediated by a transcription factor NF-kB and
mitogen-activated protein kinase (MAPK) c-Jun NH2-terminal kinase (JNK)
dependent manner. Furthermore, we found positive correlations between
synovial ﬂuid leptin and IL-6 (r=0.33, p=0.002), leptin and MMP-1 (r=0.41,
p<0.001), and leptin and MMP-3 (r=0.51, p<0.001).
Conclusions: Leptin up-regulated the production of proinﬂammatory medi-
ator IL-6, and the production of the extracellular matrix degrading enzymes
MMP-1, MMP-3, MMP-13 in human OA cartilage. The clinical relevance of
these ﬁndings was supported by positive correlations between leptin and
IL-6, MMP-1, and MMP-3 in synovial ﬂuid from OA patients. These ﬁndings
support the idea of leptin as a detrimental factor in cartilage metabolism
and as a possible link between obesity and OA.
012
FUNCTIONAL CHARACTERIZATION OF OA RISK POLYMORPHISM
RS225014 AT DIO2 IN HUMAN OA CARTILAGE
S.D. Bos1,2, J. Loughlin3, R.G. Nelissen1, P.E. Slagboom1,2, I. Meulenbelt1,2
1LUMC, Leiden, Netherlands; 2Netherlands Consortium for Healthy Ageing,
Leiden, Netherlands; 3Newcastle Univ., Newcastle, United Kingdom
Purpose: Previously, the deiodinase iodothyronine type-2 gene (DIO2) was
identiﬁed as an osteoarthritis (OA) risk gene. The protein coded by DIO2
is responsible for activation of thyroid hormone by removal of an iodine
residue from T4 thereby converting it to T3, a process occurring in several
speciﬁc tissues including the growth plate. The strongest associating SNP in
the gene rs225014 is located in an exon and codes for an amino acid change
(Thr92Ala). However, so far no major impact on protein function has been
shown and further investigation of the gene and regulation thereof may
help understand the mechanisms involved in the association of DIO2 to
OA. Functional characterization of alleles discriminated by SNP rs225014
by a differential allelic expression (DAE) assay may indicate the presence
of different genetic regulatory elements of the gene.
Methods: From subjects undergoing total joint arthroplasty we collected
OA affected and preserved cartilage from within the same joint. By geno-
typing the OA risk SNP rs225014 we identiﬁed heterozygous individuals
(N=13). From these individuals good quality RNA was extracted from the
OA affected cartilage using a milling technique combined with Qiagen midi
or mini RNeasy kits with modiﬁed protocols. We ampliﬁed a region of DIO2
containing the SNP using speciﬁc forward primers aimed at a 540 and 533
basepair fragment of genomic and cDNA (spanning 1 intron) respectively
and a reverse primer located on an exon. By use of an allele discriminating
Taqman assay (Applied Biosystems, C__15819951) the relative peak heights
of allele C and T ﬂuorescence signals was assessed on both DNA and
RNA level on an ABI 7900HT realtime PCR machine. Using genomic DNA
peak heights as a reference for a 1:1 ratio of allelic presence the RNA
derived values were corrected for technical differences of ﬂuorescence
before log transformation of the peak height ratios. Deviations from allelic
balance in the normalized log transformed RNA samples were tested
against the normalized log transformed DNA samples for signiﬁcance using
a Mann-Whitney non-parametric test.
Results: For all 13 samples we show a highly signiﬁcant allelic imbalance,
where the OA risk allele (C) was more abundantly present in OA cartilage
samples (Table 1, Figure 1).
None of the genomic DNA’s showed signiﬁcant deviations from allelic
balance when tested against all remaining genomic DNA’s. We could not
ascribe differences in DAE values to speciﬁc joint sites or gender differ-
ences. One sample (donor 8) showed an exceptionally high amount of allelic
imbalance which is followed up by sequencing of 18kb of the genomic
locus at high coverage of this speciﬁc individual and other subjects.
Conclusions: We show that the OA risk gene DIO2 is subject to highly
signiﬁcant differential allelic expression based on alleles of rs225014. The
allele C, which is a risk allele for OA presence, is more abundantly present
Table 1. Baseline characteristics of study samples
Donor Age Sex Joint cDNA (%) Genomic DNA (%) Relative C/T P-value
1 Female 70 Shoulder 18 (90) N/A 1.30 <0.01
2 Female N/A Hip 19 (95) 5 (100) 1.26 <0.01
3 Male 61 Hip 20 (100) 5 (100) 1.29 <0.01
4 Female 59 Hip 16 (80) 4 (80) 1.34 <0.01
5 Male 71 Hip 19 (95) 4 (80) 1.32 <0.01
6 Female 75 Knee 20 (100) 5 (100) 1.33 <0.01
7 Female 78 Hip 19 (95) 5 (100) 1.25 <0.01
8 Female 75 Hip 20 (100) 5 (100) 1.60 <0.01
9 Female 79 Knee 20 (100) 5 (100) 1.38 <0.01
10 Male 56 Hip 17 (85) 5 (100) 1.36 <0.01
11 Female 62 Hip 18 (90) 5 (100) 1.41 <0.01
12 Female 79 Hip 17 (85) 5 (100) 1.42 <0.01
13 Female 62 Shoulder 17 (85) 5 (100) 1.42 <0.01
Figure 1
in OA cartilage RNA of 13 subjects. The higher activity of this allele
may increase the thyroid signalling in the cartilage, which in turn directs
chondrocytes in the direction of hypertrophy and jeopardizes cartilage
integrity. To further conﬁrm this hypothesis and investigate whether the
observed DAE is present throughout all cartilage we plan to assess DAE
in the preserved cartilage obtained from the study subjects as well as
healthy cartilage obtained from control donors. Furthermore, absolute
expression levels of DIO2 in healthy, preserved and OA affected cartilage
samples may provide additional insights in the ongoing signalling of DIO2
in osteoarthritis.
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Purpose: Obesity is an important risk factor for the development of
Osteoarthritis (OA) also in non-weight bearing joints, such as the hands.
Accumulating data indicate that adipose tissue can secrete inﬂammatory
mediators with powerful immunomodulatory effects. To gain insight into
the possible mechanisms underlying the association between OA and
obesity, we have extensively characterized the immune cell composition
and release of inﬂammatory mediators by the infrapatellar fat pad (IFP),
an intra-articular adipose organ located in the knee, in the vicinity of
synovium and cartilage.
Methods: IFP and thigh subcutaneous (Sc) adipose tissue were obtained
from 47 primary OA patients (14 males and 33 females, mean body mass
index 30 kg/m2). The stromal vascular fraction (SVF) was isolated and cells
were phenotypically characterized by FACS. Adipose tissue and adipocytes
were cultured for 24h in medium and cytokine and adipokine levels in fat-
and adipocyte-conditioned media were measured by luminex.
Results: More cells (per gram adipose tissue) were present in the SVF
of the IFP than of Sc adipose tissue. Various immune cells were present
in SVF, CD14+ macrophages being the most abundant (mean approx.20%),
followed by T cells (CD3+; mean approx.10%), mast cells (CD117+FcεRI+;
mean approx.2.5%) and B cells (CD19+; mean < 1%). Although no dif-
